NPF
NPF, licence 80001043: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80001043
- Status
- Active licence
- Licence date
- 21 November 2005
- Revision date
- 30 October 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| DL-Phenylalanine Source : DL-phénylalanine | 50.0 mg | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 2775000.0 Unités de papaïne du FCC | Not calculated |
| Eschscholzia californica Source : Plante entière Extract : Solide Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25.0 mg | Not calculated |
| Salix alba Source : Jeune écorce de branche Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75.0 mg | Not calculated |
| Potassium Source : Citrate de potassium | 12.5 mg | 75,000 µg |
| Niacinamide Source : Niacinamide | 25.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Assist in pain-relieving/anti-inflammatory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist, please consult a healthcare practitioner. Do not take during pregnancy or breastfeeding. Do not take this product if you are sensitive to aspirin or aspirin-similar compound. Do not use in individuals with known or suspected sensitivity to the listed ingredients. Do not take this product if you take antibiotic,anticoagulants, antithrombotic agents, MAO inhibitor or other drugs. Do not take if you suffer from anxiety attacks, diabetes, high blood pressure, phenylketonurla (PKU) or pre-existing pigmented melanoma.
Source
Official Health Canada record, licence 80001043
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.